Reimbursed Care Access in Montenegro

Currently classified as a strictly controlled substance under Montenegro’s national drug laws and treated as illegal for possession, production and distribution outside of authorised research. There is no authorised medical/therapeutic psilocybin program or public reimbursement pathway; authorised access would be limited to approved clinical trials. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorised medical use outside of approved clinical research and with criminal penalties for unauthorised possession, manufacture, or distribution. There is no national, reimbursed MDMA-assisted therapy program in Montenegro. #

Esketamine (marketed as Spravato) has received centralised marketing authorisation in the EU (authorisation valid throughout EU member states via the EMA on 18 December 2019), but Montenegro is not an EU member state and there is no evidence of an established, nationally reimbursed esketamine treatment program in Montenegro. Where esketamine is authorised in a jurisdiction it is typically restricted to specialist psychiatric settings with strict monitoring and often subject to specific reimbursement/coverage decisions; in Montenegro, any access would require a local marketing authorisation or special import/compassionate use approval and would not be part of an established public reimbursement pathway. # #

Ketamine is listed on the WHO Model List of Essential Medicines as an injectable anaesthetic and is widely used in clinical anaesthesia and emergency medicine; this global status means that ketamine is routinely available for legitimate medical uses in many health systems, including in hospital anaesthesia practice. However, the typical psychiatric/off‑label use of ketamine for depression (e.g., repeated intravenous infusions in outpatient psychiatric programs) does not have an established, publicly reimbursed program in Montenegro and would generally be provided (if available) through private clinics or as part of authorised clinical research rather than as standard state‑funded mental health care. For anaesthetic indications ketamine is an essential medicine (WHO); for psychiatric/esketamine indications, see EMA (Spravato) for the regulated product pathway in Europe. # #

Currently classified as a strictly controlled substance under national law and internationally controlled under the 1971 UN Convention on Psychotropic Substances; there is no authorised medical programme or reimbursement for DMT in Montenegro outside of formally approved clinical research. Natural preparations containing DMT (e.g., ayahuasca) are likewise not an authorised medical therapy in Montenegro. # #

Currently classified as a strictly controlled substance under Montenegro’s drug laws with no authorised medical use outside of approved clinical research. Personal possession or distribution is criminalised; there is no reimburseable medical pathway. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorised medical use outside of approved clinical research. There is no national, reimbursed ibogaine treatment program in Montenegro. #

Because ayahuasca preparations contain DMT, their possession, importation or distribution falls under the same restrictions as DMT and they are not authorised for medical use or reimbursement in Montenegro outside of approved research or narrowly‑granted exemptions (which are not reported as existing). # #

Currently classified as a strictly controlled substance under Montenegro’s national drug laws and has no authorised medical or reimbursed therapeutic use outside of approved clinical research. Peyote/mescaline ceremonial exemptions that exist in some jurisdictions are not documented as lawful pathways in Montenegro. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorised medical use or reimbursement outside of approved clinical research. All 2C family compounds are treated as illicit/substituted controlled psychotropic substances in Montenegro’s enforcement framework. #